OTCMKTS:ITHUF

iAnthus Capital Stock Forecast, Price & News

$0.26

0.00 (0.00 %)

(As of 03/5/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.22

Now: $0.26▼

$0.27

50-Day Range

$0.19

MA: $0.33▼

$0.46

52-Week Range

$0.05

Now: $0.26▼

$0.79

Volume853,036 shs

Average Volume1.82 million shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

iAnthus Capital Holdings, Inc. develops, owns, and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. Its products include smokable flower and pre-rolls; concentrates, such as vaporizer cartridges, wax products, tinctures, topicals, etc.; cannabis infused edibles; and various cannabidiol (CBD) products. The company also distributes and retails CBD products to dispensaries and retail stores, as well as online. As of July 31, 2020, it operated 36 dispensaries in 11 states. The company is based in Vancouver, Canada.

Headlines

Outdoorsy Appoints New Chief Financial Officer, Chief Operating Officer
February 18, 2021 | finance.yahoo.com

Settlement proposed in class action on behalf of Crown Wards who were victims of crime but did not receive certain compensatory benefits
February 11, 2021 | finance.yahoo.com

Viridian Chart Of The Week: How Much Is Liquidity Worth? (It's Complicated)
January 28, 2021 | benzinga.com

KCSA 2021 Psychedelics Investor Conference: What You Need To Know
January 27, 2021 | benzinga.com

Captor Capital Opens One Plant Dispensary In Antioch
January 13, 2021 | benzinga.com

iAnthus Announces Filing of Form 10 Registration Statement
December 8, 2020 | finance.yahoo.com

Puritan (once again) beats Copan in German lawsuits and gets cost reimbursements too
December 7, 2020 | finance.yahoo.com

Recent Trading Activity of iAnthus Stock
December 4, 2020 | finance.yahoo.com

iAnthus Reports Fiscal Third Quarter 2020 Financial Results and Provides Update on Executive Team
November 27, 2020 | finance.yahoo.com

iAnthus Capital Holdings, Inc. (ITHUF)
November 1, 2020 | finance.yahoo.com

iAnthus Reports Fiscal Second Quarter 2020 Financial Results
October 15, 2020 | prnewswire.com

Final Court Order Hearing
September 18, 2020 | finance.yahoo.com

Leading Independent Proxy Advisory Firms Support iAnthus' Proposed Arrangement Resolution
September 1, 2020 | finance.yahoo.com

iAnthus Corrects Purported Shareholders' Group's Inaccurate and Misleading Statements
August 28, 2020 | finance.yahoo.com

iAnthus Mails Information Circular in Connection with its Recapitalization Transaction
August 18, 2020 | finance.yahoo.com

Ianthus Capital EPS misses by $1.21, beats on revenue
August 14, 2020 | seekingalpha.com

iAnthus Reports Fiscal First Quarter 2020 Financial Results
August 14, 2020 | finance.yahoo.com

Cannabis Movers & Shakers: iAnthus, Advanced Vapor, Terrascend, CBD Dog Health
August 7, 2020 | benzinga.com

iAnthus Obtains Interim Court Order and Announces Meeting Details in Connection with its Recapitalization Transaction
August 7, 2020 | finance.yahoo.com

iAnthus Reports Fiscal 2019 Financial Results and Provides Additional Business Updates
July 31, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Drug Manufacturers - Specialty & Generic

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:ITHUF

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.ianthuscapital.com

Phone646-518-9411

Employees233

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.58 out of 5 stars

Medical Sector

1377th out of 1,969 stocks

Drug Manufacturers - Specialty & Generic Industry

30th out of 61 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for iAnthus Capital.

2.9 Community Rank

Outperform Votes
iAnthus Capital has received 50 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
iAnthus Capital has received 37 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
iAnthus Capital has received 57.47% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about iAnthus Capital and other stocks. Vote “Outperform” if you believe ITHUF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ITHUF will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
iAnthus Capital does not currently pay a dividend.
Dividend Growth
iAnthus Capital does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, iAnthus Capital insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

$0.26

0.00 (0.00 %)

(As of 03/5/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive ITHUF News and Ratings via Email

Sign-up to receive the latest news and ratings for ITHUF and its competitors with MarketBeat's FREE daily newsletter.

iAnthus Capital (OTCMKTS:ITHUF) Frequently Asked Questions

Is iAnthus Capital a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iAnthus Capital in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" iAnthus Capital stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ITHUF, but not buy additional shares or sell existing shares.
View analyst ratings for iAnthus Capital or view top-rated stocks.

What stocks does MarketBeat like better than iAnthus Capital?

Wall Street analysts have given iAnthus Capital a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but iAnthus Capital wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has iAnthus Capital's stock price been impacted by COVID-19 (Coronavirus)?

iAnthus Capital's stock was trading at $0.5282 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ITHUF shares have decreased by 50.8% and is now trading at $0.26.
View which stocks have been most impacted by COVID-19.

Who are iAnthus Capital's key executives?

iAnthus Capital's management team includes the following people:

Mr. Randy Maslow, Co-Founder, Pres, MD, Interim CEO & Director (Age 65, Pay $600k)
Mr. Julius John Kalcevich, CFO & Corp. Sec. (Age 47, Pay $450k)
Mr. Robert R. Galvin, Sr. VP, Chief Admin. Officer & Interim COO (Age 60)
Ms. Megan W. Kulick CFA, VP of Investor Relations
Dr. Richard J. Boxer, Chief Medical Officer
Mr. Michael R. Woolston, Sr. VP of Manufacturing, Supply Chain & Quality

Who are some of iAnthus Capital's key competitors?

Some companies that are related to iAnthus Capital include (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Abacus Health Products (ABAHF), Acreage (ACRGF), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE) and CannPal Animal Therapeutics (CP1).
View all of ITHUF's competitors.

What is iAnthus Capital's stock symbol?

iAnthus Capital trades on the OTCMKTS under the ticker symbol "ITHUF."

How do I buy shares of iAnthus Capital?

Shares of ITHUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iAnthus Capital's stock price today?

One share of ITHUF stock can currently be purchased for approximately $0.26.

How many employees does iAnthus Capital have?

iAnthus Capital employs 233 workers across the globe.

What is iAnthus Capital's official website?

The official website for iAnthus Capital is www.ianthuscapital.com.

How can I contact iAnthus Capital?

The company can be reached via phone at 646-518-9411.

This page was last updated on 3/7/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here